<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                            Published final edited form  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Mol Microbiol. 2009 March ; 71(6): 1386&#226;&#8364;&#8220;1401. doi:10.1111/j.1365-2958.2009.06610.x. <br />  <br />  <br />  <br />                            Methylene tetrahydrofolate dehydrogenase/cyclohydrolase                            synthesis 10-CHO-THF essential Leishmania major <br />  <br />                            Silvane M. F. Murta*,&#194;&#167;, Tim J. Vickers*, David  Scott&#194;&#167;&#194;&#167;, Stephen M. Beverley1 <br />                            Department Molecular Microbiology, Box 8230, Washington University School Medicine, 660 <br />                            S. Euclid Avenue, St. Louis, MO 63110, USA <br />  <br />                            Summary <br />                                 10-formyl tetrahydrofolate key metabolite C1 carbon metabolism, arising action <br />                                 formate-tetrahydrofolate ligase (FTL) 5,10-methenyltetrahydrofolate cyclohydrolase/5,10- <br />                                 methylene tetrahydrofolate dehydrogenase (DHCH). Leishmania major possesses single DHCH1 <br />                                 FTL genes encoding exclusively cytosolic proteins, unlike organisms isoforms occur <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 mitochondrion  Recombinant DHCH1 showed typical NADP+-dependent methylene <br />                                 tetrahydrofolate DH 5,10-methenyltetrahydrofolate CH activities, DH activity                                 potently inhibited substrate analog 5,10 THF (Ki 105 nM), Leishmania growth <br />                                 (EC50 1.1 &#206;&#188;M). Previous studies showed null ftl&#226;&#710;&#8217; mutants normal, raising possibility                                 loss purine synthetic pathway rendered 10-CHO-THF dispensable evolution.                                 unable generate dhch1&#226;&#710;&#8217; null mutants gene replacement, despite using wide spectrum                                 nutritional supplements expected bypass DHCH function. applied improved method                                 testing essential genes Leishmania, based segregational loss episomal complementing <br />                                 genes transfection; analysis ~1400 events successful loss DHCH1                                 established requirement. Lastly, employed &#226;&#8364;&#732;genetic metabolite complementation&#226;&#8364;&#8482; using <br />                                 ectopically expressed FTL alternative source 10-CHO-THF; dhch1&#226;&#710;&#8217; null parasites                                 readily obtained. data establish requirement 10-CHO tetrahydrofolate metabolism L. <br />                                 major, provide genetic pharmacological validation DHCH target chemotherapy, <br />                                 potentially protozoan parasites. <br />  <br />  <br />                            Keywords <br />                                 trypanosomatid protozoa; C1-THF metabolism; 1 carbon transfer; chemotherapy; formyl methionyl- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 tRNA <br />  <br />  <br />                            Introduction <br />                                             Leishmania important pathogens infecting millions people worldwide. symptoms <br />                                             infections range skin lesions disfiguring necrosis face, lethal <br />                                             pathology liver spleen, depending Leishmania species involved.                                             lasting immunity possible, vaccine presently available, drugs used                                             chemotherapy suffer various deficiencies, toxicity, high cost emerging <br />  <br />  <br />                            1For correspondence. E-mail: E-mail: beverley@borcim.wustl.edu. Tel. (+1) 314-747-2632; FAX. (+1) 314-747-2634;. <br />                             authors contributed equally work <br />                            &#194;&#167;Present address: Centro Pesquisas Rene Rachou, FIOCRUZ, Belo Horizonte, Minas Gerais, 30190-002, Brazil <br />                            &#194;&#167;&#194;&#167;Present address: Burnham Institute Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037 <br />                            Supplemental information &#226;&#8364;&#339;Methylene tetrahydrofolate dehydrogenase/cyclohydrolase synthesis 10-CHO-THF                            essential Leishmania major&#226;&#8364;?, Silvane M. F. Murta, Tim J. Vickers, David  Scott, Stephen M. Beverley. <br />                             Murta et al.                                                                                               Page 2 <br />  <br />  <br />                                           resistance (Kedzierski et al., 2006, Mishra et al., 2007). Consequently, development                                           alternative therapies urgent priority. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Folate derivatives essential cellular cofactors synthesis <span id='am-114' about='obo:IMR_0200384' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-115' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-116' property="oboInOwl:id" content="IMR:0200384" datatype="xsd:string"></span><span id='am-117' property="rdfs:label" content="Thymidine" datatype="xsd:string"></span><span id='am-118' property="oboInOwl:hasDbXref" content="KEGG:C00214" datatype="xsd:string"></span>thymidine</span>, purines                                           amino acids <span id='am-75' about='obo:IMR_0100118' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-76' property="oboInOwl:hasExactSynonym" content="Gly" datatype="xsd:string"></span><span id='am-77' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-78' property="oboInOwl:id" content="IMR:0100118" datatype="xsd:string"></span><span id='am-79' property="oboInOwl:hasAlternativeId" content="IMR:0200057" datatype="xsd:string"></span><span id='am-80' property="rdfs:label" content="glycine" datatype="xsd:string"></span><span id='am-81' property="rdfs:label" content="Gly" datatype="xsd:string"></span><span id='am-82' property="oboInOwl:hasDbXref" content="KEGG:C00037" datatype="xsd:string"></span><span id='am-83' property="oboInOwl:hasExactSynonym" content="Glycine" datatype="xsd:string"></span><span id='am-84' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-85' property="rdfs:label" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-86' property="oboInOwl:hasExactSynonym" content="Aminoacetic acid" datatype="xsd:string"></span>glycine</span> methionine, metabolism histidine serine (Nzila et al., <br />                                           2005, Christensen <span id='am-5' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-6' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span>amp</span>; MacKenzie, 2006) mitochondrial protein synthesis                                           formylation initiator methionyl-tRNAMet (Kozak, 1983). metabolism reduced folate <br />                                           cofactors particular drug discovery, dihydrofolate reductase (DHFR)                                           efficiently targeted anti-tumor anti-microbial chemotherapy (Nzila et al., 2005, <br />                                           Schweitzer et al., 1990,  2004). current antifolates ineffective                                           Leishmania DHFR inhibition bypassed pteridine reductase 1 (PTR1),                                           relatively insensitive (Bello et al., 1994), combined inhibitor strategies overcome                                           (Hardy et al., 1997, Cavazzuti et al., 2008). work explore potential new arena                                           chemotherapy, enzymes responsible synthesis 10-formyl tetrahydrofolate (10- <br />                                           CHO-THF). <br />  <br />                                           known enzyme activities mediate production 10-CHO-THF (Fig. 1) (Christensen &amp; <br />                                           Mackenzie, 2008,Christensen &amp; MacKenzie, 2006,Appling, 1991). pathway formate                                           added directly THF <span id='am-17' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-18' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-21' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span>ATP</span>-dependent reaction formate-tetrahydrofolate ligase <br />                                           (FTL, EC 6.3.4.3) (Rabinowitz &amp; Pricer, 1962). Alternatively, 10-CHO-THF arises                                           steps 5,10-methylene-tetrahydrofolate (5,10-CH2-THF), beginning oxidation NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           5,10-methenyl-tetrahydrofolate (5,10-CH=THF) NADP+ NAD+-dependent <br />                                           methylenetetrahydrofolate dehydrogenase (DH, EC 1.5.1.5 1.5.1.15, respectively) (Moore <br />                                           et al., 1974,Hatefi et al., 1957). 5,10-CH=THF hydrolyzed 10-CHO-THF                                           methenyltetrahydrofolate cyclohydrolase (CH, EC 3.5.4.9). enzymes occur physically <br />                                           various combinations, monofunctional enzymes human, bacterial plant <br />                                           FTLs, bifunctional enzymes dehydrogenase cyclohydrolase activities (referred                                           DHCH enzymes), trifunctional enzymes activities (referred C1-THF <br />                                           synthases) (Christensen &amp; Mackenzie, 2008,Christensen &amp; MacKenzie, 2006,Appling, <br />                                           1991,Nour &amp; Rabinowitz, 1991,Tan et al., 1977). Adding complexity, multiple genes <br />                                           encode activities single organism, humans expressing trifunctional <br />                                           C1-synthase cytoplasm (MTHFD1), bifunctional DHCH (MTHFD2)                                           monofunctional FTL (MTHFD1L) targeted mitochondrion (Christensen et al., 2005b). <br />                                           eukaryotes express differing combinations cytosolic organellar DHCH                                           FTLs (Christensen &amp; MacKenzie, 2006,Hanson &amp; Roje, 2001). <br />  <br />                                           products enzymes known functions. 5,10-CH=THF best- <br />                                           known intermediate leading 10-CHO-THF (Hanson &amp; Roje, 2001, Christensen &amp; <br />                                           MacKenzie, 2006, Appling, 1991), occurs DNA photolyases, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           functions mammalian histidine catabolism (Weber, 2005, Stanger, 2002). pathways <br />                                           described Leishmania properties organisms suggest                                           unlikely essential. 10-CHO-THF acts formyl donor purine biosynthesis,                                           bacteria eukaryotic organelles formylation initiator methionyl-tRNAMet                                           produce fMet-tRNAMet (Appling, 1991, Christensen &amp; MacKenzie, 2006, RajBhandary, <br />                                           1994, Varshney et al., 1993, Kozak, 1983). Interestingly, protozoans including <br />                                           trypanosomes Leishmania lack novo purine pathway rely exclusively salvage <br />                                           (Carter et al., 2008), eliminating need 10-CHO-THF capacity. importance <br />                                           initiator Met-tRNAMet formylation subject controversy. thought <br />                                           originally essential bacteria, recent data suggest case (Newton <br />                                           et al., 1999, RajBhandary, 2000). Mitochondrial initiator Met-tRNAMet formylation                                           dispensable yeast Saccharomyces cerevisae required humans;                                           essential, consequences loss vary widely (Li et al., 2000, Spencer &amp; Spremulli, <br />                                           2004, Vial et al., 2003). Studies protozoal parasite Trypanosoma brucei, member  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                              Page 3 <br />  <br />  <br />                                           protozoal subfamily Trypanosomatidae Leishmania belongs, Met-tRNA <br />                                           imported mitochondrion formylated, used mitochondrial <br />                                           protein synthesis (Tan et al., 2002, Charriere et al., 2005). RNAi knockdown formyl- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Met-tRNAMet transferase (FMT) shows little phenotype.  negative results RNAi <br />                                           knockdowns arise incomplete inhibition, particular problem                                           cofactor metabolism low levels THF-dependent metabolites fulfill normal <br />                                           metabolic needs. Importantly, simultaneous RNAi knockdown T. brucei FMT                                           mitochondrial initiation factor IF2 yield significant growth inhibition (Charriere et al., 2005), <br />                                           possibly signifying importance fMet-tRNAMet essential mitochondrial protein <br />                                           synthesis. <br />  <br />                                           Previously used database mining survey 10-CHO-THF synthetic pathway <br />                                           Leishmania trypanosomatids (Vickers et al., 2008, Opperdoes &amp; Coombs, <br />                                           2007). L. major genome encodes active monofunctional FTL predicted <br />                                           bifunctional DHCH encoded DHCH1 gene. proteins localized exclusively <br />                                           cytoplasm consistent absence predicted N terminal mitochondrial targeting <br />                                           sequence, shown immunoblotting cellular fractions GFP fusions                                           DHCH1 (Vickers et al., 2008). Unexpectedly, ftl&#226;&#710;&#8217; null mutants showed normal viability                                           virulence. noted  absence purine synthesis mitigates need 10-CHO- <br />                                           THF Leishmania, potentially reduce eliminate requirement <br />                                           globally. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           characterize role DHCH1 L. major metabolism enzymatic, genetic <br />                                           knockout, pharmacological tests. DHCH1 encodes functional protein <br />                                           NADP-dependent DH CH activities, kinetic properties similar seen                                           organisms. used traditional transfection-based new plasmid segregational <br />                                           approach establish DHCH1 essential. Notably, expression FTL enabled                                           recovery dhch1&#226;&#710;&#8217; mutants, establishing &#226;&#8364;&#732;genetic metabolite complementation&#226;&#8364;&#8482;                                           10-CHO-THF essential. Lastly showed Leishmania growth DHCH1 activity                                           inhibited specific DHCH inhibitor. total data provide genetic                                           pharmacological validation DHCH target anti-parasitic chemotherapy. <br />  <br />                               Results <br />                               Enzymatic activity recombinant L. major DHCH1 <br />                                           Previously used database mining trypanosomatid genomes identify gene LmjF26.0320 <br />                                           DHCH1 functional DHCH Leishmania major (Vickers et al., 2008).                                           hexahistidine-tagged DHCH1 expressed E. coli recombinant protein                                           purified metal-affinity chromatography (Supplementary Figure S1) (Vickers et al., 2008). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Dehydrogenase activity measured following conversion 5,10-CH2-THF 5,10- <br />                                           CH=THF, cyclohydrolase activity monitored following consumption                                           5,10-CH=THF, yielding 10-CHO-THF  methods). Purified DHCH1 showed 5,10- <br />                                           CH2-THF dehydrogenase 5,10-CH=THF cyclohydrolase activities, specific activities <br />                                           22 &#194;&#177; 2 6.3 &#194;&#177; 0.8 &#206;&#188;mol min&#226;&#710;&#8217;1 mg&#226;&#710;&#8217;1, respectively. comparison activities                                           porcine cytosolic multifunctional C1-synthase L. major enzyme slightly higher <br />                                           dehydrogenase activity lower cyclohydrolase activity, porcine enzyme having <br />                                           activities 7.5 22 &#206;&#188;mol min&#226;&#710;&#8217;1 mg&#226;&#710;&#8217;1, respectively (Tan et al., 1977). <br />  <br />                                           kinetic properties dehydrogenase reaction determined summarized                                           Table 1. reaction followed typical Michaelis-Menten kinetics saturated                                           substrate. mammals, cytoplasmic DH activity trifunctional C1-synthase                                           dependent NADP+ (Tan et al., 1977), mitochondrial DH dependent NAD <br />                                           + (Mejia &amp; MacKenzie, 1988). L. major DHCH1 dehydrogenase activity highly <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                               Page 4 <br />  <br />  <br />                                           dependent NADP+, activity detected NAD+ (limit detection 0.3 &#206;&#188;mol <br />                                           min&#226;&#710;&#8217;1 mg&#226;&#710;&#8217;1, 1% activity seen NADP+). DH activity human <br />                                           mitochondrial DHCH NAD+ requires phosphate magnesium ions (Christensen et <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           al., 2005a), tested presence 5 mM (K+)PO4 5 mM MgCl2 L. major <br />                                           DHCH1 showed NAD+-dependent activity (data shown). data consistent <br />                                           conservation residues LmDHCH1 interact NADP+ cofactor                                           human cytosolic enzyme, notably Arg173 interacts coenzyme 2&#226;&#8364;&#8482; phosphate group <br />                                           human enzyme&#226;&#8364;&#8482;s active site (Allaire et al., 1998) (Fig. S2). comparison human <br />                                           enzymes, Leishmania DHCH1 dehydrogenase activity appears similar                                           NADP+-dependent cytoplasmic C1 synthase, lower Km coenzyme lower <br />                                           turnover human mitochondrial DHCH MTHFD2 (Pawelek &amp; MacKenzie, 1998). <br />  <br />                               Attempts generate DHCH1 knockout &#226;&#8364;&#732;classic&#226;&#8364;&#8482; double replacements <br />                                           Leishmania predominantly diploid inactivation genes requires rounds <br />                                           gene replacement (Cruz et al., 1991). chromosomes aneuploidy                                           WT Leishmania strains, preliminary CGH data suggest Chromosome 26 bearing <br />                                           DHCH1 disomic L. major line studied (E. Kruvand S. Beverley,                                           preparation).  constructed targeting fragments, DHCH1 ORF replaced <br />                                           ones encoding puromycin (PAC) hygromycin B (HYG) resistance, flanked ~ 1 kb                                           5&#226;&#8364;&#178; 3&#226;&#8364;&#178; sequence (Fig. 2A). Electroporation fragment separately WT L. major <br />                                           followed plating selective media yielded transfectant colonies efficiently control <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           frequencies  shown). Analysis 20 clonal transfectant lines showed                                           heterozygotes (DHCH1/&#206;&#8221;dhch1::PAC DHCH1/&#206;&#8221;dhch1::HYG, abbreviated                                           PAC/+ HYG/+) expected (Fig 2A, Supplementary Figure S3, data shown).                                           studies used PCR tests primer pairs containing located outside targeting <br />                                           fragment 5&#226;&#8364;&#178; 3&#226;&#8364;&#178;  partnered marker-specific primer (Fig. S3, 2B, 2C <br />                                           data shown). <br />  <br />                                           HYG/+ PAC/+ heterozygotes submitted second round electroporation <br />                                           remaining targeting fragment (PAC HYG respectively) plated semisolid <br />                                           media containing puromycin hygromycin B. PCR tests 12 doubly resistant clonal <br />                                           transfectant lines showed contained planned HYG PAC DHCH1 <br />                                           replacements (Fig 2B, 2C). Nonetheless, clonal transfectants retained copy DHCH1, <br />                                           revealed PCR amplification intact DHCH1 ORF (Fig. 2D), grew normally (data <br />                                           shown). finding successful &#226;&#8364;&#732;double replacement&#226;&#8364;&#8482; accompanied retention                                           WT gene seen previously attempts target essential genes Leishmania, <br />                                           arising generation aneuploid tetraploid parasites additional chromosomes <br />                                           bearing target gene (Balana-Fouce et al., 2008, Cruz et al., 1993, Dumas et al., 1997, Ilgoutz <br />                                           et al., 1999a, Vergnes et al., 2005). Analysis DNA content doubly-targeted lines <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           flow cytometry showed WT DNA contents (data shown), suggested                                           likely aneuploids, bearing &#226;&#8364;&#732;WT&#226;&#8364;&#8482; chromosome planned <br />                                           HYG PAC replacements (Fig. 2A). <br />  <br />                               Attempts generate DHCH1 knockout double replacement using different nutritional <br />                               supplements <br />                                           attempted bypass consequences DHCH1 ablation metabolic <br />                                           complementation. studies, 2nd round transfections repeated,                                           parasites grown plated media containing various supplements potentially able bypass <br />                                           DHCH1 requirement. included metabolites known participate arise                                           C1 folate metabolism, including <span id='am-87' about='obo:IMR_0100118' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-88' property="oboInOwl:hasExactSynonym" content="Glycine" datatype="xsd:string"></span><span id='am-89' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-90' property="rdfs:label" content="glycine" datatype="xsd:string"></span><span id='am-91' property="oboInOwl:hasExactSynonym" content="Gly" datatype="xsd:string"></span><span id='am-92' property="oboInOwl:hasAlternativeId" content="IMR:0200057" datatype="xsd:string"></span><span id='am-93' property="rdfs:label" content="Gly" datatype="xsd:string"></span><span id='am-94' property="oboInOwl:id" content="IMR:0100118" datatype="xsd:string"></span><span id='am-95' property="rdfs:label" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-96' property="oboInOwl:hasExactSynonym" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-97' property="oboInOwl:hasDbXref" content="KEGG:C00037" datatype="xsd:string"></span><span id='am-98' property="rdfs:label" content="Glycine" datatype="xsd:string"></span>glycine</span>, serine, formate, tetrahydrofolate, thymidine                                           folinic acid. Second, parasites grown supplements plus C1 folates <br />                                           5,10-CH=THF 10-formylfolic acid (10-CHOFA), intermediate <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                             Page 5 <br />  <br />  <br />                                           metabolite formed DH activity DHCH1 second constituting potential <br />                                           precursor 10-formyl-THF. ideal supplement 10-CHO-THF,                                           metabolite unstable;  mildly alkaline pH Leishmania culture media <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           (7.4), spontaneous isomerization 5,10-CH=THF 10-CHO THF occurs time <br />                                           (Rabinowitz, 1963, Brouwer et al., 2007). Lastly, expected role 10-CHO-THF                                           Leishmania arises role mitochondrial protein synthesis, attempted bypass <br />                                           potential requirement performing transfections presence pyruvate <span id='am-109' about='obo:IMR_0200021' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-110' property="rdfs:label" content="Uridine" datatype="xsd:string"></span><span id='am-111' property="oboInOwl:hasDbXref" content="KEGG:C00299" datatype="xsd:string"></span><span id='am-112' property="oboInOwl:id" content="IMR:0200021" datatype="xsd:string"></span><span id='am-113' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>uridine</span>, <br />                                           metabolites proposed bypass need mitochondrial DNA                                           presumably proteins encoded (Sen et al., 2007). <br />  <br />                                           total, 65 independent clonal lines analyzed, yielded presumptive <br />                                           aneuploidy phenotype PCR assay described (data shown), e. parasites <br />                                           bearing planned HYG PAC replacements retaining copy                                           DHCH1 ORF, recovery dhch1&#226;&#710;&#8217; null mutants. <br />  <br />                               Deletion chromosomal DHCH1 presence ectopically expressed DHCH1 <br />                                           important control successful targeting achieved presence                                           ectopic DHCH1 expression, render unlikely possibility molecular events <br />                                           anticipated tested strategy occurred.  DHCH1 expressed <br />                                           multicopy episomal pXNG4 vector, bears nourseothricin (SAT) resistance <br />                                           marker (D. Scott S. Beverley, preparation). DHCH assays WT protein extracts showed <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           specific activity 1 nmol&#226;&#710;&#8217;1 min&#226;&#710;&#8217;1 mg, value significantly different assay <br />                                           background controls lacking NADP+, WT/pXNG4-DHCH1 transfectants showed <br />                                           specific activity 31 nmol&#226;&#710;&#8217;1 min&#226;&#710;&#8217;1 mg, 30-fold greater. pXNG4-DHCH1                                           introduced HYG/+ PAC/+ heterozygotes described previously, second <br />                                           chromosomal allele lines targeted transfection (Fig. 3A). visualize                                           chromosomal DHCH1 allele, PCR using forward primer located 5&#226;&#8364;&#178; outside                                           DHCH1 targeting fragment reverse primer located DHCH1 ORF used <br />                                           (Fig. 3B). <br />  <br />                                           contrast results parasites lacking ectopic DHCH1 expression,                                           chromosomal DHCH1 readily lost 12 independent clonal transfectants tested <br />                                           (Fig. 3B). PCR tests showed lines contained HYG PAC &#206;&#8221;dhch1&#226;&#710;&#8217; <br />                                           replacements, retaining DHCH1 ORF borne pXNG4-DHCH1 (data shown). <br />                                            presence ectopically expressed DHCH1, chromosomal DHCH1 alleles <br />                                           successfully eliminated, yielding parasites genetically dhch1&#226;&#710;&#8217;/+pXNG4- <br />                                           DHCH1. methodological controls support conclusion                                           conditions tested, DHCH1 essential. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Genetic metabolite complementation permits recovery DHCH1 replacement <br />                                           requirement DHCH1 somewhat surprising, Leishmania possess second <br />                                           cytoplasmic pathway 10-CHO-THF synthesis formyl tetrahydrofolate ligase <br />                                           (FTL), enzymatic activity verified (Vickers et al., 2008) (Fig. 1).                                           indicate DHCH1 unanticipated function, alternatively, activity                                           FTL pathway insufficient metabolic needs absence DHCH1.  evidence <br />                                           FTL pathway secondary importance comes fact ftl&#226;&#710;&#8217; mutants                                           readily generated apparent effect growth vitro virulence animal <br />                                           infections (Vickers et al., 2008). <br />  <br />                                           asked provision 10-CHO-THF expression FTL using                                           multicopy episomal vector pXNG4-FTL bypass requirement DHCH1 (Fig. 4A). <br />                                           pXNG4-FTL introduced heterozygous +/PAC +/HYG lines, FTL  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                               Page 6 <br />  <br />  <br />                                           expression confirmed western blot analysis (Supplementary Figure S4). parasites <br />                                           submitted second round targeting  Analysis 12 independent <br />                                           transfectant lines showed lacked DHCH1 ORF entirely, western blot <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           analysis polyclonal anti-DHCH1 antiserum confirmed complete loss DHCH1 <br />                                           protein (Fig. 4B, C). ability elevated FTL expression enable parasites readily <br />                                           dispense DHCH1 strong evidence genetic metabolite complementation, presumably <br />                                           product FTL activity, 10-CHO-THF, turn argues strongly essential <br />                                           role DHCH1 provision metabolite. <br />  <br />                               Forcing loss pXNG4-DHCH1 negative selection <br />                                           final test probing essentiality DHCH1 WT Leishmania, applied method <br />                                           building &#226;&#8364;&#732;plasmid shuffling&#226;&#8364;&#8482; approaches common yeast genetics. Plasmid segregation <br />                                           based approaches advantage allowing separation tests gene function                                           transfection, relatively inefficient (D. Scott S.M. Beverley, preparation).                                           studies utilized features episomal pXNG4 vector, presence                                           negative selective marker  modified HSV thymidine kinase gene) positive GFP <br />                                           fluorescence marker (Fig. 5A). starting point dhch1&#226;&#710;&#8217;/pXNG4-DHCH1 parasite <br />                                           described earlier, chromosomal DHCH1 ablated parasite growth maintained <br />                                           episomal pXNG4-DHCH1 (Fig. 3, 5A). <br />  <br />                                           dhch1&#226;&#710;&#8217;/pXNG4-DHCH1 parasites grown briefly (24 h, ~3 doublings) absence <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           nourseothricin (selective SAT marker episomal pXNG4) presence                                           ganciclovir, action HSV TK selects parasites bearing pXNG4. <br />                                           period little effect parasite growth seen.  parasites subjected                                           flow cytometry, assess plasmid copy number following expression GFP marker. <br />                                           populations cells evident following treatment:  &#226;&#8364;&#732;bright&#226;&#8364;&#8482; cells showing <br />                                           strong fluorescence (&gt;200 FU; M2 gate Fig. 5B) presumably high copy numbers                                           pXNG4-DHCH1; &#226;&#8364;&#732;dim&#226;&#8364;&#8482; cells, showing background fluorescence (2&#226;&#8364;&#8220;20 FU; M1 gate                                           Fig. 5B), presumably lacking pXNG4-DHCH1, bearing just copies. Controls <br />                                           showed absence ganciclovir dhch1&#226;&#710;&#8217;/+pXNG4-DHCH1 parasites retained high <br />                                           GFP fluorescence, WT cells showed background fluorescence (Fig. 5C, 5D).                                           previous results indicated DHCH1 essential, expected &#226;&#8364;&#732;bright&#226;&#8364;&#8482; cells <br />                                           retaining pXNG4-DHCH1 viable, &#226;&#8364;&#732;dim&#226;&#8364;&#8482; cells suffer growth <br />                                           disadvantage perish. <br />  <br />                                           used flow cytometry select single cells individual wells 96 microtiter plate, <br />                                           focusing &#226;&#8364;&#732;dim&#226;&#8364;&#8482; (M1) &#226;&#8364;&#732;bright&#226;&#8364;&#8482; (M2) parasites M1 population shown Fig. <br />                                           5B. inoculated parasites plates containing M199 media containing puromycin                                           hygromycin B  guarantee retention dhch1&#226;&#710;&#8217; cells) lacking ganciclovir nourseothricin <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           (pXNG4 markers). experiments performed media supplemented additionally <br />                                           various metabolites described earlier. <br />  <br />                                           studies, 478/672 wells inoculated single &#226;&#8364;&#732;bright&#226;&#8364;&#8482; parasite grew (71 <br />                                           %), value similar seen controls probing effects sorting, recovery growth <br />                                           single cells cells (50 &#226;&#8364;&#8220; 80%). contrast, wells receiving single &#226;&#8364;&#732;dim&#226;&#8364;&#8482; parasite, <br />                                           growth seen 48/2016 (2.4 %) (Fig. 5B). Importantly, 48 &#226;&#8364;&#732;dim&#226;&#8364;&#8482; parasite lines <br />                                           retained pXNG4-DHCH1 plasmid, judged ability grow presence                                           nourseothricin (SATR) DHCH1 PCR tests. presume cells arose                                           imperfect sorting, cells originally expressing low levels GFP presence <br />                                           copies pXNG4-DHCH1. correcting intrinsic plating <br />                                           efficiency, estimate total approximately 1430 cells (71% 2016) scored <br />                                           ability grow absence DHCH1. plasmid shuffling enabled extend <br />  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                              Page 7 <br />  <br />  <br />                                            stringency selection total 65 events scored &#226;&#8364;&#732;classic&#226;&#8364;&#8482; transfection <br />                                            based approach, value 20-fold higher. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Interaction L. major DHCH1 novel antifolates <br />                                            corroborate conclusion DHCH activity essential Leishmania growth,                                            turned pharmacological tests. substrate analogue 5,10 THF ((2S)-2-[[4-[(6aR)-3- <br />                                            amino-1,9-dioxo-5,6,6a,7-tetrahydro-4H- imidazol[3,4-f]pteridin-8-yl]benzoyl]amino] <br />                                            pentanedioic acid) previously shown potent inhibitor DHCH activity                                            human cytosolic C1-synthase (Tonkinson et al., 1998, Temple et al., 1982). predicted                                            compound potent inhibitor Leishmania DHCH1, based overall <br />                                            sequence conservation, including residues shown intact inhibitor structural <br />                                            studies human C1-synthase DHCH domain (Schmidt et al., 2000) (Fig. S2).  <br />                                            5,10 THF potent inhibitor DH activity recombinant Leishmania DHCH1, <br />                                            data fitting simple competitive model respect 5,10-CH2-THF, giving                                            Ki 105 &#194;&#177; 2 nM (Fig. 6). 10-fold higher Ki 18 &#194;&#177; 5 nM seen                                            DH activity human cytosolic C1-synthase (Schmidt et al., 2000). 5,10 THF <br />                                            shown previously weak inhibitor human DHFR (Ki &gt; 100 &#206;&#188;M) (Temple et <br />                                            al., 1982), 100 &#206;&#188;M 5,10 THF did inhibit activity Leishmania DHFR-TS (data <br />                                            shown) FTL (Vickers et al., 2008). L. major DHCH1 inhibited pteridine <br />                                            analogues shown previously inhibit L. major DHFR PTR1, including methotrexate                                            hydrophobic diamino-quinazoline, -pyrimidine -pteridine analogues (compound 34: 2,4- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            diamino-6-(3,4-dichlorophenoxy)-quinazoline); compound 70; 2,4-diamino-6-benzyl-5-(3- <br />                                            phenylpropyl)-pyrimidine compound 25 (2,4-diamino-6,7-diisopropylpteridine) (Hardy <br />                                            et al., 1997, Bello et al., 1994) (tested 50 &#206;&#188;M; data shown). <br />  <br />                               Toxicity folate analogues cell lines <br />                                            5,10 THF inhibited L. major growth EC50 1.1 &#194;&#177; 0.04 &#206;&#188;M (Table 2). Parasites <br />                                            overexpressing DHCH1 (WT/pXNG4-DHCH1 dhch1&#226;&#710;&#8217;/+pXNG4-DHCH1) showed 4&#226;&#8364;&#8220;5 <br />                                            fold resistance (p &lt; 0.0001 p &lt; 0.0003, respectively; Table 2), consistent studies <br />                                            purified DHCH  Parasites overexpressing FTL (WT/pXNG4-FTL dhch1&#226;&#710;&#8217;/pXNG4- <br />                                            FTL) showed 3-fold resistance (p &lt; 0.0001 p &lt; 0.0002, respectively; Table 2), implying <br />                                            FTL activity act metabolic pass DHCH inhibition. Consistent                                            enzyme inhibition data, DHCH1 FTL overexpressors did resistance                                            methotrexate hydrophobic antifolates tested (compounds 34 70; Table <br />                                            2). Interestingly, absence DHCH target (dhch1&#226;&#710;&#8217;/pXNG4-FTL line), growth <br />                                            inhibited EC50 &#206;&#188;M range (Table 2), suggesting 5,10 THF                                            targets Leishmania. FTL excluded sensitive 5,10 THF,                                            bridged structure inhibitor does closely resemble 10-CHO-THF, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            probable target folate-dependent enzymes transporters                                            cell. <br />  <br />                               Discussion <br />                                            L. major expresses active bifunctional NADP+-dependent DHCH <br />                                            encoded DHCH1 (Table 1). Previous studies localized DHCH1 protein parasite <br />                                            cytosol, consistent predicted lack N terminal mitochondrial targeting sequence <br />                                            NADP dependency DH activity (Vickers et al., 2008). Attempts generate <br />                                            dhch1&#226;&#710;&#8217; null mutants homologous replacement unsuccessful, despite analysis large <br />                                            number independent events use metabolic supplements shown organisms <br />                                            rescue DHCH-deficiency. Instead, studies invariably yielded parasites bearing                                            planned replacements, bearing extra copies DHCH1 likely arose                                            aneuploidy. unusual Leishmania phenotype recovery planned replacements,  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                             Page 8 <br />  <br />  <br />                                           retention target gene aneuploidy tetraploidy, widely used                                           indication gene gene essential organism. technical control, chromosomal <br />                                           dhch1&#226;&#710;&#8217; replacements readily obtained ectopic expression DHCH1. Lastly, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           applied plasmid shuffling approach allowed increase number events analyzed <br />                                           20 fold: 65 classic transfectional approaches, 1,400 negative <br />                                           selection cell sorting.  unable recover viable dhch1&#226;&#710;&#8217; null mutant <br />                                            virtues potential &#226;&#8364;&#732;plasmid shuffle&#226;&#8364;&#8482; methodology Leishmania discussed <br />                                           . confident concluding DHCH1 essential gene L. <br />                                           major circumstances. <br />  <br />                                           Notably, able completely remove DHCH1 following ectopic expression FTL, <br />                                           provides alternative metabolic route 10-CHO-THF synthesis formate <br />                                           tetrahydrofolate ligase activity. form &#226;&#8364;&#732;genetic metabolic complementation&#226;&#8364;&#8482; suggests <br />                                           parasite dependency DHCH1 activity arises provision ultimate <br />                                           metabolite FTL DHCH1, 10-CHO-THF. Hypothetically, active metabolite <br />                                           5,10-CH=THF, metabolites interconvert significant rates                                           physiological conditions, precludes measurement individual abundance                                           cell (Brouwer et al., 2007).  known essential role metabolism <br />                                           5,10-CH=THF, intermediate 10-CHO-THF synthesis, favor <br />                                           conclusion 10-CHO-THF relevant metabolite. <br />  <br />                                           Interestingly, levels WT FTL activity appear insufficient rescue dhch1&#226;&#710;&#8217; parasites, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           consistent previous finding null mutant ftl&#226;&#710;&#8217; parasites phenotypically normal <br />                                           grown vitro fully infective susceptible mice (Vickers et al., 2008). <br />                                           Hypothetically, possible elevated FTL synthesis alterations 10-CHO-THF <br />                                           metabolism bypass requirement DHCH1 circumstances,                                           studies able detect second site mutations including FTL gene <br />                                           amplification selections forcing loss DHCH1 (S. Murta S. Beverley, <br />                                           unpublished data). <br />  <br />                               role 10-CHO-THF Trypanosomatid metabolism? <br />                                           mammals, known roles 10-CHO-THF include provision formyl groups purine <br />                                           biosynthesis, intermediate C1-THF interconversions involved <span id='am-33' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-34' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-36' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-39' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span>amino acid</span> metabolism <br />                                           (glycine, methionine, histidine, serine), production fMet- tRNAMet                                           mitochondrion (Appling, 1991, Christensen &amp; MacKenzie, 2006).  Leishmania                                           known purine auxotrophs genome lacks purine biosynthetic enzymes <br />                                           glycinamide ribonucleotide (GAR) phosphoribosylaminoimidazolecarboxamide <br />                                           (AICAR) transformylases (EC 2.1.1.2 2.1.2.3 respectively) (Carter et al., 2008). Similarly, <br />                                           studies established Leishmania require amino acids arising NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           C1-pathway normal growth (Scott et al., 2008, Vickers et al., 2008).                                           conditions tested, formylation initiator Met-tRNAMet currently stands                                           candidate essential metabolic role. discussed earlier, extent fMet- tRNAMet <br />                                           synthesis required matter debate, differences seen studies                                           species eukaryotes prokaryotes.  conclusion                                           Leishmania require fMet-tRNAMet consistent finding related <br />                                           trypanosomatid parasite T. brucei requires formylated initiator methionyl-tRNAMet                                           mitochondrial protein synthesis survival (Tan et al., 2002, Charriere et al., 2005).                                           suggest cytoplasmic 10-CHO-THF arising FTL DHCH1 activity <br />                                           cytosol transported mitochondrion. generally thought                                           metabolites reduced folates principal route communication cytosolic- <br />                                           mitochondrial C1-dependent pathways mammalian cells (Appling, 1991), studies <br />  <br />  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                   Page 9 <br />  <br />  <br />                                           point trafficking C1 tetrahydrofolates cytosol mitochondrion plants <br />                                           (Prabhu et al., 1998, Hanson et al., 2000). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           interpretations rest strength accuracy current genome-based models <br />                                           Trypanosomatid metabolomes. Given substantial number hypothetical proteins                                           unknown function encoded Trypanosomatid genomes (Peacock et al., 2007, Ivens et al., <br />                                           2005, El-Sayed et al., 2005, Berriman et al., 2005), exclude possibility                                           Leishmania possess novel essential pathways require 10-CHO-THF.  L. <br />                                           major genome predicts highly degenerate pseudogene (pseDHCH2) DHCH2-related <br />                                           sequences completely absent L. braziliensis African trypanosome genomes <br />                                           (Peacock et al., 2007, Ivens et al., 2005, El-Sayed et al., 2005, Berriman et al., 2005). contrast, <br />                                           seemingly intact DHCH2s occur L. infantum, L. mexicana, Crithidia fasciculata                                           Trypanosoma cruzi, predicted proteins conservation DHCH active site residues <br />                                           (Vickers et al., 2008). Interestingly, GFP tagged LiDHCH2 localized mitochondrion <br />                                           expressed L. donovani (Vickers et al., 2008), able                                           demonstrate DHCH activity associated expression WT LiDHCH2 (data                                           shown). Potentially occurrence catalytically active DHCH2 signify increased <br />                                           importance mitochondrial 10-CHO-THF synthesis trypanosomatid species.                                           future, direct studies mitochondrial fMet-tRNAMet synthesis mediated FMT                                           DHCH2 enzymatically active trypanosomatids possess test                                           hypotheses. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Plasmid segregation shuffling improved test gene function <br />                                           Currently, standard approach determining gene essential Leishmania                                           inability delete chromosomal alleles homologous gene replacement (Cruz et al., <br />                                           1991, Barrett et al., 1999). Fortunately, studies facilitated fact homologous <br />                                           recombination occurs far frequently non-homologous insertions trypanosomatids <br />                                           (Beverley, 2003, Clayton, 1999). Ignoring technical failures, general experience                                           investigators attempts delete essential genes Leishmania yield parasites <br />                                           bearing planned allelic replacements containing additional gene copies arise                                           aneuploidy polyploidy (Cruz et al., 1993, Dumas et al., 1997, Ilgoutz et al., 1999b, Vergnes <br />                                           et al., 2005, Balana-Fouce et al., 2008). considered diagnostic criterion, <br />                                           especially accompanied successful replacement presence ectopic gene. <br />  <br />                                           challenge gene replacement-based approach relative inefficiency                                           transfection (10&#226;&#710;&#8217;4 , limiting number events scored. example,                                           analyzed 65 events targeting copy DHCH1, number exceeding typically <br />                                           reported tests Leishmania gene function. factors impinging replacement-based <br />                                           approaches include transfection efficiencies vary greatly depending locus NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           targeting construct used (Papadopoulou &amp; Dumas, 1997), survivors emerge <br />                                           mutations unrelated targeted gene (unpublished data). contrast, plasmid <br />                                           shuffling approach, functional tests arise segregation ectopically expressed gene <br />                                           borne plasmid bearing positive (GFP) negative (TK) markers, line previously <br />                                           engineered lack gene (Fig. 5). Following brief period culture allow <br />                                           segregation episomal vector, large number candidate &#226;&#8364;&#732;segregants&#226;&#8364;&#8482; obtained <br />                                           appropriate manipulations GFP TK markers, rapidly tested. allowed <br />                                           rapidly score ~1400 segregants DHCH1, 20 times number achieved <br />                                           traditional methods, necessary tested. believe <br />                                           plasmid segregation method provides significant improvement tests essential <br />                                           gene function Leishmania, established yeast Saccharomyces cerevisiae <br />                                           (Forsburg, 2001). future envisage number applications based                                           approach &#226;&#8364;&#732;plasmid shuffling&#226;&#8364;&#8482;. <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                             Page 10 <br />  <br />  <br />                               DHCH1 10-CHO-THF metabolism target anti-parasitic chemotherapy <br />                                           L. major folate metabolism shows differences human hosts, including <br />                                           bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS) (Coderre et al., <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           1983), novel pteridine reductase (PTR1) (Bello et al., 1994), large complex family                                           folate biopterin transporters (Ouellette et al., 2002), cytosolic mitochondrial <br />                                           synthesis 10-CHO-THF (Vickers et al., 2008),  factors contribute                                           profound differences antifolate sensitivity; example, relative insensitivity PTR1 <br />                                           antifolates ability act metabolic bypass DHFR inhibition accounts <br />                                           relative lack efficacy drugs Leishmania (Bello et al., 1994, Nare et <br />                                           al., 1997). <br />  <br />                                           folate metabolizing enzymes essential Leishmania (DHFR-TS, <br />                                           folylpolyglutamyl-synthase) (Cruz &amp; Beverley, 1990, El Fadili et al., 2002), tested <br />                                           appear largely wholly dispensable growth virulence, including methylene <br />                                           tetrahydrofolate reductase glycine cleavage complex (Scott et al., 2008, Vickers et <br />                                           al., 2006). reflect ability parasite salvage sufficient quantities                                           C1-THF dependent metabolites amino acids purines (Carter et al., 2008, Scott et <br />                                           al., 1987), particularly mammalian stages parasite reside                                           phagolysosomes postulated rich free amino acids (McConville et al., 2007). <br />                                           contrast, unable rescue requirement DHCH1 wide array                                           metabolites known postulated rescue DHCH deficiency. reflect factors <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           including deficiency non-salvageable metabolite, conclusion consistent                                           essential requirement mitochondrial fMet-tRNAMet. <br />  <br />                                           parasite enzyme good drug target essential parasite survival, <br />                                           dispensable, absent, substantially different host (Fairlamb, 2002). mammals <br />                                           cystosolic mitochondrial forms DHCH (MTHFD1 MTHFD2 respectively) <br />                                           essential early development (Di Pietro et al., 2002, Brody et al., 2002, Parle-McDermott <br />                                           et al., 2005).  human fibroblasts lacking enzyme viable, purine                                           glycine auxotrophs (Christensen et al., 2005b, Patel et al., 2003), 10-CHO-THF <br />                                           metabolism dispensable yeast S. cerevisiae grown rich media (West et al., <br />                                           1996). suggests adult tissues human host dependent DHCH <br />                                           activity Leishmania. contrast, 10-CHO-THF pathway simplified parasitic <br />                                           protozoans, species synthesize single cytosolic DHCH FTL (L. major, L. <br />                                           braziliensis), synthesize just cytosolic DHCH (African trypanosomes) (Vickers <br />                                           et al., 2008). Preliminary genomic analysis suggest like African trypanosomes, malaria <br />                                           parasite P. falciparum possess single route 10-CHO-THF synthesis, bifunctional <br />                                           DHCH (Nzila et al., 2005). data suggest relative simplicity 10-CHO-THF <br />                                           pathway parasitic protozoa relative human host render sensitive NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           chemotherapeutic interventions. <br />  <br />                                           DHCH inhibitors developed, L. major DHCH1 activity promastigote <br />                                           growth vitro sensitive substrate analog 5,10 THF (Temple et al., 1982).                                           specificity inhibitor supported findings DHCH1 overexpressors                                           susceptible, fails inhibit DHFR FTL enzymatic activity.  expression <br />                                           FTL did completely overcome 5,10 THF inhibition suggesting                                           targets DHCH1. <br />  <br />                                           Consistent genetic studies  DHCH inhibitors little activity toxicity <br />                                           mammalian cells vitro, mouse cancer models, concentrations 10 &#206;&#188;M <br />                                           (Tonkinson et al., 1998, Temple et al., 1982). preliminary studies modest activity <br />                                           5,10 THF Leishmania amastigotes macrophages (EC50 ~ 5 &#206;&#188;M),                                           host cell toxicity seen 10 &#206;&#188;M (S. Hickerson S. Beverley, unpublished data). <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                              Page 11 <br />  <br />  <br />                                           results encouraging 5,10 THF actually selective host                                           parasite enzymes (Ki = 18 v. 105 nM respectively; (Schmidt et al., 2000) Fig. 6). highly <br />                                           conserved, numerous differences Leishmania DHCH1 human cytosolic NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           mitochondrial DHCHs (Fig. S2) exploited design selective potent <br />                                           inhibitors. DHCH inhibitors received high priority cancer chemotherapy programs <br />                                           poor efficacy ones tested, number antifolates targeting 10- <br />                                           CHO-THF utilizing enzymes GAR transformylase developed (Zhang et <br />                                           al., 2003). Possibly, similar pharmacophores hold promise targeting 10-CHO-THF <br />                                           metabolism Leishmania Trypanosomatids. <br />  <br />                               EXPERIMENTAL PROCEDURES <br />                               Reagents <br />                                           (6-R,S)-Tetrahydrofolate (THF) 5,10-CH=THF obtained Schircks Laboratories <br />                                           (Jona, Switzerland). (2S)-2-[[4-[(6aR)-3-amino-1,9-dioxo-5,6,6a,7-tetrahydro-4H- imidazo <br />                                           [3,4-f]pteridin-8-yl]benzoyl]amino]pentanedioic acid (5,10 THF) custom <br />                                           synthesized SAFC Pharma, division Sigma-Aldrich Corporation, according                                           method Temple et al. (Temple et al., 1982); compound 96.2% pure high- <br />                                           performance liquid chromatography. Methotrexate compound 25 (2,4-Diamino-6,7- <br />                                           diisopropylpteridine) purchased Sigma, folate analogues compound 34 (2,4- <br />                                           diamino-6-(3,4-dichlorophenoxy)-quinazoline) compound 70 (2,4-diamino-6-benzyl-5- <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           (3-phenylpropyl)-pyrimidine) described (Hardy et al., 1997). Hygromycin B (HYG) <br />                                           purchased Calbiochem (EMD Biosciences, San Diego, CA) nourseothricin <br />                                           (SAT) Werner BioAgents (Jena, Germany). chemicals reagents                                           analytical grade purchased Sigma-Aldrich. <br />  <br />                               Parasite growth drug inhibition <br />                                           studies used derivatives L. major clone Friedlin V1 promastigotes, grown 27&#194;&#176;C                                           M199 medium  Biologicals) supplemented 40 mM 4-(2-hydroxyethyl)-1- <br />                                           piperazineethanesulfonic acid (HEPES) pH 7.4, 50 &#206;&#188;M <span id='am-40' about='obo:IMR_0100126' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-41' property="oboInOwl:hasExactSynonym" content="Adenine riboside" datatype="xsd:string"></span><span id='am-42' property="rdfs:label" content="adenosine" datatype="xsd:string"></span><span id='am-43' property="rdfs:label" content="Adenosine" datatype="xsd:string"></span><span id='am-44' property="rdfs:label" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:id" content="IMR:0100126" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasExactSynonym" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasDbXref" content="KEGG:C00212" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:hasAlternativeId" content="IMR:0200246" datatype="xsd:string"></span><span id='am-49' property="rdfs:label" content="Adenine riboside" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:hasExactSynonym" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-51' property="obo:IAO_0000115" content="A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter." datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-53' property="rdfs:label" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasExactSynonym" content="Adenosine" datatype="xsd:string"></span>adenosine</span>, 1 &#206;&#188;g ml&#226;&#710;&#8217;1 biotin, 5 &#206;&#188;g <br />                                           ml&#226;&#710;&#8217;1 hemin, 2 &#206;&#188;g ml&#226;&#710;&#8217;1 biopterin 10 % (v/v) heat-inactivated fetal calf serum. Growth                                           determined seeding parasites 5 &#195;&#8212; 105 cells ml&#226;&#710;&#8217;1 various concentrations drug                                           counting cells using model Z1 Coulter counter cultures reached late-log phase.                                           EC50 value concentration drug required decrease growth 50%. <br />  <br />                                           Cloning L. major DHCH1 DHCH1 coding sequence amplified                                           recombinant Pfu DNA polymerase (Stratagene) using L. major genomic DNA template, <br />                                           prepared LiCl mini-prep method (Medina-Acosta &amp; Cross, 1993), using primers <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           SMB3528 SMB3529, added 5&#226;&#8364;&#178; NdeI 3&#226;&#8364;&#178; BamHI sites, respectively. amplified <br />                                           product cloned pCR.blunt (Invitrogen), yielding pCR.blunt. DHCH1 (B6255)                                           NdeI-BamHI fragment transferred corresponding sites pET15b (Novagen), yielding <br />                                           pET15b-LmjDHCH1 (B6026). <br />  <br />                               Expression, purification enzymatic assays recombinant L. major DHCH1 <br />                                           Protein expressed E. coli pET15b-LmjDHCH1 purified metal-affinity <br />                                           chromatography, described supplemental methods. purification storage <br />                                           protein inclusion 10% glycerol buffers required prevent loss                                           activity. manner, enzyme flash-frozen loss activity. DHCH <br />                                           activities measured spectrophotometrically, using temperature-controlled Beckman <br />                                           DU-640 spectrophotometer, essentially described Tan et al. (Tan et al., 1977) following <br />                                           formation 5,10-CH=THF 5,10-CH2-THF (DH activity) conversion                                           5,10-CH=THF 10-CHO-THF (CH activity). 5,10-CH2-THF dehydrogenase assays  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                           Page 12 <br />  <br />  <br />                                           carried 0.5 ml volume 27&#194;&#176;C contained 25 mM MOPS, pH 7.3, 250 &#206;&#188;M THF, <br />                                           2.5 mM <span id='am-104' about='obo:IMR_0200017' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-105' property="rdfs:label" content="Formaldehyde" datatype="xsd:string"></span><span id='am-106' property="oboInOwl:hasDbXref" content="KEGG:C00067" datatype="xsd:string"></span><span id='am-107' property="oboInOwl:id" content="IMR:0200017" datatype="xsd:string"></span><span id='am-108' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>formaldehyde</span>, 1 mM NADP+ 30 mM 2-mercaptoethanol. Assays                                           preincubated 5 min allow formation 5,10-CH2-THF reactions initiated NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           addition enzyme. reactions stopped 5 min addition equal <br />                                           volume 1 M HCl 5,10-CH=THF produced quantified 350 nm, using extinction <br />                                           coefficient 24.9 mM&#226;&#710;&#8217;1 cm&#226;&#710;&#8217;1. DH activity expressed &#206;&#188;moles 5,10-CH=THF produced <br />                                           minute. Formaldehyde stocks freshly-prepared paraformaldehyde, THF <br />                                           dissolved just use 250 mM triethanolamine-Cl, pH 7, 40 mM 2-mercaptoethanol. <br />                                           Cyclohydrolase activity measured 0.5 ml assays 27&#194;&#176;C containing 25 mM MOPS, pH <br />                                           7.3, 30 mM 2-mercaptoethanol 50 &#206;&#188;M 5, 10-CH=THF. hydrolysis 5,10-CH=THF <br />                                           followed 355 nm, non-enzymatic rate subtracted. <br />  <br />                                           Enzyme inhibition measured using dehydrogenase assay, stocks hydrophobic <br />                                           diaminoquinazolines diaminopteridines dissolved DMSO, 5,10 THF dissolved <br />                                           250 mM triethanolamine-Cl, pH 7, 40 mM 2-mercaptoethanol, THF, stored                                           &#226;&#710;&#8217;80 &#194;&#176;C. 5,10 THF custom synthesized Sigma-Aldrich <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="rdfs:label" content="chemical" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span>Chemical</span> Pvt.  <br />                                           (Bangalore, India); authenticity procuct supported infrared spectroscopy                                           proton NMR estimated greater 96% pure. Data 5,10 THF <br />                                           inhibition assays fitted competitive, non-competitive, uncompetitive mixed <br />                                           inhibition models non-linear regression using Sigmaplot. DHFR activity                                           bifunctional L. major DHFR-TS measured described (Hardy et al., 1997). Activity NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           drug assays expressed percentage drug DMSO control. <br />  <br />                               DHCH1 replacement constructs <br />                                           Fusion PCR (Szewczyk et al., 2006) used generate deletion constructs,                                           contained puromycin (PAC) hygromycin (HYG) drug-resistance cassettes                                           5&#226;&#8364;&#178; 3&#226;&#8364;&#178; LmjDHCH1 flanking sequences (Szewczyk et al., 2006). Briefly, flanking <br />                                           sequences drug resistance cassettes amplified separately PCR using primers                                           produce overlapping ends. 5&#226;&#8364;&#178; 3&#226;&#8364;&#178; LmjDHCH1 flanking sequences (743 726 bp), <br />                                           amplified using primers SMB2772/2656 2657/2773 added SphI                                           BamHI site, respectively. PAC HYG drug-resistance cassettes (600 1026 bp)                                           amplified using primers SMB2557/2558 SMB2561/2562, respectively added                                           linker sequence. deletion construct mixing purified PCR products <br />                                           flanking sequences drug-resistance cassette using products templates <br />                                           second round PCR. PCR reactions generate PAC HYG constructs <br />                                           used external primers SMB2772 2773, fused flanking sequences                                           correct drug resistance cassette. deletion constructs cloned pGEM- <br />                                           T (Promega), yielding pGEM-T.5&#226;&#8364;&#178;. PAC.3&#226;&#8364;&#178;. LmjDHCH1 (B4827) pGEM-T.5&#226;&#8364;&#178;. HYG.3&#226;&#8364;&#178;. <br />                                           LmjDHCH1 (B4827). sequences constructs confirmed restriction <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           mapping sequencing. <br />  <br />                               DHCH1 replacement transfections <br />                                           DHCH1-targeting fragments digested SphI BamHI, linear targeting <br />                                           fragments containing PAC (2.1 kb) HYG (2.5 kb) transfected separately wild-type <br />                                           (WT) L. major FV1 promastigotes described (Robinson &amp; Beverley, 2003). Heterozygous <br />                                           clones, DHCH1/&#206;&#8221;dhch1::PAC DHCH1/&#206;&#8221;dhch1::HYG (referred PAC/+ HYG/+),                                           isolated plating semisolid M199 medium containing 30 &#206;&#188;g ml&#226;&#710;&#8217;1 puromycin 50 &#206;&#188;g <br />                                           ml&#226;&#710;&#8217;1 hygromycin B, respectively. Heterozygous PAC/+ HYG/+ clones transfected <br />                                           deletion constructs containing HYG PAC cassettes. parasites plated                                           semisolid M199 medium containing 30 &#206;&#188;g ml&#226;&#710;&#8217;1 puromycin 50 &#206;&#188;g ml&#226;&#710;&#8217;1 hygromycin.                                           attempts rescue growth DHCH1&#226;&#710;&#8217;/&#226;&#710;&#8217; homozygotes different mixtures                                           different supplements added plating medium. basic supplements  glycine <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                                Page 13 <br />  <br />  <br />                                            (1 mg ml&#226;&#710;&#8217;1), serine (0.1 mg ml&#226;&#710;&#8217;1), formate (5 mM), THF (5 &#206;&#188;M), thymidine (10 &#206;&#188;g ml&#226;&#710;&#8217;1)                                            folinic acid (10 &#206;&#188;g ml&#226;&#710;&#8217;1). Additional supplements added basic mixture                                            plates,  5,10-CH=THF (10 &#206;&#188;M), 10-formylfolic acid 10-CHOFA (10 &#206;&#188;M)  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            alternatively, uridine (0.1 mg ml&#226;&#710;&#8217;1) sodium pyruvate (1 mM). DNA contents                                            permeabilized RNAse treated cells measured propidium iodide staining using flow <br />                                            cytometry (Cruz et al., 1993). <br />  <br />                               PCR primers assessing chromosomal DHCH1 PAC HYG replacements <br />                                            Generation planned PAC HYG replacements confirmed PCR, using primer <br />                                            located 5&#226;&#8364;&#178; (SMB2731) 3&#226;&#8364;&#178; (SMB2771) DHCH1 ORF targeting fragment primer <br />                                            located PAC HYG genes (SMB2557/2558 SMB2561/2562). loss                                            DHCH1 ORFs confirmed using primers specific chromosomal DHCH1 allele <br />                                            (SMB3125/3126) using forward primer located chromosome 5&#226;&#8364;&#178; (SBM2731)                                            DHCH1 ORF targeting fragment reverse primer located DHCH1 gene <br />                                            (SMB3126). <br />  <br />                               pXNG4 expression constructs <br />                                            DHCH1 FTL ORFs amplified primers (SMB3125/3126 SMB3123/3124, <br />                                            respectively) L. major genomic DNA, adding flanking BglII sites, CCACC sequence <br />                                            preceding initiation codon. DHCH1 FTL ORFs inserted pGEM-T <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            (Promega) yielding pGEM-DHCH1 (B6029) pGEM-FTL (B6030); DHCH1                                            FTL ORFs extracted BglII digestion inserted BglII site pXNG4 <br />                                            (B5840) create pXNG4-DHCH1 (B6031) pXNG4-FTL (B6032). <br />  <br />                                            plasmids transfected wild-type L. major FV1, heterozygote lines <br />                                            (DHCH1/&#206;&#8221;dhch1::PAC DHCH1/&#206;&#8221; dhch1:: HYG) transformants isolated  <br />                                            using plating media containing 100 &#206;&#188;g ml&#226;&#710;&#8217;1 nourseothricin 30 &#206;&#188;g ml&#226;&#710;&#8217;1 puromycin <br />                                            50 &#206;&#188;g ml&#226;&#710;&#8217;1 hygromycin. presence plasmid confirmed PCR FACS analysis <br />                                            presence SAT GFP markers, respectively. colonies expressing FTL <br />                                            DHCH1 submitted second replacement using PAC HYG targeting <br />                                            fragments. parasites isolated plating semi-solid M199 media containing 100 <br />                                            &#206;&#188;g ml&#226;&#710;&#8217;1 nourseothricin, 30 &#206;&#188;g ml&#226;&#710;&#8217;1 puromycin 50 &#206;&#188;g ml&#226;&#710;&#8217;1 hygromycin. <br />  <br />                               Single-cell sorting <br />                                            Prior flow cytometry, dhch1&#226;&#710;&#8217;/pXNG4-DHCH1 lines incubated 50 &#206;&#188;g ml&#226;&#710;&#8217;1 <br />                                            ganciclovir M199 media 24 h. Single cells sorting performed based                                            GFP fluorescence described Results. Cells resuspended phosphate-buffered <br />                                            saline, filtered CellTrics 50 &#206;&#188;m filters remove clumps (Partec). Single cells <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            recovered using Dako MoFlo high-speed cell sorter placed individual <br />                                            wells 96 plates, containing 150 &#206;&#188;l M199 medium. Plates incubated 27&#194;&#176; C <br />                                            1&#226;&#8364;&#8220;2 weeks parasite growth scored. <br />  <br />                               Supplementary Material <br />                                            Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                               Acknowledgments <br />                                            thank  Hanson M. Ouellette discussions. thank Sushil Rajan Sigma-Aldrich Chemical Pvt.  <br />                                            custom synthesis 5,10 THF. Single-cell sorting assistance staff high-speed <br />                                            sorter core, Alvin J. Siteman Cancer Center, Washington University Medical School. Siteman Cancer Center                                            supported NCI Cancer Center Support Grant #P30 CA91842. work supported National Institutes <br />  <br />  <br />  <br />  <br />                                                  Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                      Page 14 <br />  <br />                                           Health Grant AI21903  S.M.B.); Brazilian agencies: CNPq FAPEMIG  S.M.F.M.) European <br />                                           Molecular Biology Organization long term fellowship ALTF 106&#226;&#8364;&#8220;2005  T. V.). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Abbreviations <br />                                           THF <br />                                                          tetrahydrofolate <br />  <br />                                           10-CHO-THF <br />                                                    10-formyl tetrahydrofolate <br />  <br />                                           5,10-CH=THF <br />                                                     5,10-methenyl-tetrahydrofolate <br />  <br />                                           5,10-CH2-THF <br />                                                      5,10-methylene-tetrahydrofolate <br />  <br />                                           DHCH1 <br />                                                          gene encoding Leishmania cytosolic methenyltetrahydrofolate cyclohydrolase/ <br />                                                          5,10-methylenetetrahydrofolate dehydrogenase <br />  <br />                                           FTL <br />                                                          formate-tetrahydrofolate ligase <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           DHFR-TS <br />                                                          dihydrofolate reductase-thymidylate synthase <br />  <br />                                           WT <br />                                                          wild-type <br />  <br />                                           DH <br />                                                          dehydrogenase <br />  <br />                                           CH <br />                                                          cyclohydrolase <br />  <br />                               References <br />                                           Allaire M, Li Y, MacKenzie  Cygler M. 3-D structure folate-dependent dehydrogenase/ <br />                                             cyclohydrolase bifunctional enzyme 1.5 resolution. Structure 1998;6:173&#226;&#8364;&#8220;182. [PubMed: <br />                                             9519408] <br />                                           Appling DR. Compartmentation folate-mediated carbon metabolism eukaryotes. Faseb J <br />                                             1991;5:2645&#226;&#8364;&#8220;2651. [PubMed: 1916088] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Balana-Fouce R, Garcia-Estrada C, Perez-Pertejo Y, Reguera RM. Gene disruption DNA <br />                                             topoisomerase IB small subunit induces non-viable phenotype hemoflagellate Leishmania <br />                                             major. BMC Microbiol 2008;8:113. [PubMed: 18611247] <br />                                           Barrett MP, Mottram JC, Coombs GH. Recent advances identifying validating drug targets                                             trypanosomes leishmanias. Trends Microbiol 1999;7:82&#226;&#8364;&#8220;88. [PubMed: 10081086] <br />                                           Bello AR, Nare B, Freedman D, Hardy L, Beverley SM. PTR1: reductase mediating salvage oxidized <br />                                             pteridines methotrexate resistance protozoan parasite Leishmania major. Proc Natl Acad <br />                                             Sci U S 1994;91:11442&#226;&#8364;&#8220;11446. [PubMed: 7972081] <br />                                           Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, Bartholomeu DC, Lennard NJ, Caler E, <br />                                             Hamlin NE, Haas B, Bohme U, Hannick L, Aslett MA, Shallom J, Marcello L, Hou L, Wickstead B, <br />                                             Alsmark UC, Arrowsmith C, Atkin RJ, Barron AJ, Bringaud F, Brooks K, Carrington M, Cherevach <br />                                              Chillingworth TJ, Churcher C, Clark LN, Corton CH, Cronin  Davies RM, Doggett J, Djikeng  <br />                                             Feldblyum T, Field MC, Fraser  Goodhead  Hance  Harper D, Harris BR, Hauser H, Hostetler <br />                                             J, Ivens  Jagels K, Johnson D, Johnson J, Jones K, Kerhornou AX, Koo H, Larke N, Landfear S, <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                    Page 15 <br />  <br />  <br />                                             Larkin C, Leech V, Line  Lord  Macleod  Mooney PJ, Moule S, Martin DM, Morgan GW, <br />                                             Mungall K, Norbertczak H, Ormond D, Pai G, Peacock CS, Peterson J, Quail MA, Rabbinowitsch E, <br />                                             Rajandream MA, Reitter C, Salzberg SL, Sanders M, Schobel S, Sharp S, Simmonds M, Simpson AJ, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Tallon L, Turner CM, Tait  Tivey AR, Van Aken S, Walker D, Wanless D, Wang S, White B, White <br />                                             O, Whitehead S, Woodward J, Wortman J, Adams MD, Embley TM, Gull K, Ullu E, Barry JD, <br />                                             Fairlamb AH, Opperdoes F, Barrell BG, Donelson JE, Hall N, Fraser CM, et al. genome                                             African trypanosome Trypanosoma brucei. Science 2005;309:416&#226;&#8364;&#8220;422. [PubMed: 16020726] <br />                                           Beverley SM. Protozomics: trypanosomatid parasite genetics comes age. Nat Rev Genet 2003;4:11&#226;&#8364;&#8220; <br />                                             19. [PubMed: 12509749] <br />                                           Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy  O&#226;&#8364;&#8482;Leary VB, Parle- <br />                                             McDermott  Scott JM, Swanson DA. polymorphism, R653Q, trifunctional enzyme <br />                                             methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/ <br />                                             formyltetrahydrofolate synthetase maternal genetic risk factor neural tube defects: report                                             Birth Defects Research Group. J Hum Genet 2002;71:1207&#226;&#8364;&#8220;1215. [PubMed: 12384833] <br />                                           Brouwer VD, Zhang GF, Storozhenko S, Straeten DV, Lambert  pH stability individual folates <br />                                             critical sample preparation steps prevision analysis plant folates. Phytochem Anal <br />                                             2007;18:496&#226;&#8364;&#8220;508. [PubMed: 17624887] <br />                                           Carter NS, Yates P, Arendt CS, Boitz JM, Ullman B. Purine pyrimidine metabolism                                               Leishmania. Adv Exp Med Biol 2008;625:141&#226;&#8364;&#8220;154. [PubMed: 18365665] <br />                                           Cavazzuti  Paglietti G, Hunter WN, Gamarro F, Piras S, Loriga M, Allecca S, Corona P, McLuskey <br />                                               K, Tulloch L, Gibellini F, Ferrari S, Costi MP. Discovery potent pteridine reductase inhibitors                                               guide antiparasite drug development. Proc Natl Acad Sci U S 2008;105:1448&#226;&#8364;&#8220;1453. [PubMed: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               18245389] <br />                                           Charriere F, Tan TH, Schneider  Mitochondrial initiation factor 2 Trypanosoma brucei binds <br />                                               imported formylated elongator-type tRNA(Met). J Biol Chem 2005;280:15659&#226;&#8364;&#8220;15665. [PubMed: <br />                                               15731104] <br />                                           Christensen KE, MacKenzie  Mitochondrial carbon metabolism adapted specific needs <br />                                               yeast, plants mammals. Bioessays 2006;28:595&#226;&#8364;&#8220;605. [PubMed: 16700064] <br />                                           Christensen KE, Mackenzie  Chapter 14. Mitochondrial methylenetetrahydrofolate dehydrogenase, <br />                                               methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetases. Vitam Horm <br />                                               2008;79:393&#226;&#8364;&#8220;410. [PubMed: 18804703] <br />                                           Christensen KE  Mirza  Berghuis  Mackenzie  Magnesium phosphate ions enable NAD <br />                                               binding methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase. J <br />                                               Biol Chem 2005a;280:34316&#226;&#8364;&#8220;34323. [PubMed: 16100107] <br />                                           Christensen KE, Patel H, Kuzmanov U, Mejia NR, MacKenzie  Disruption mthfd1 gene reveals <br />                                               monofunctional 10-formyltetrahydrofolate synthetase mammalian mitochondria. J Biol Chem <br />                                               2005b;280:7597&#226;&#8364;&#8220;7602. [PubMed: 15611115] <br />                                           Clayton CE. Genetic manipulation kinetoplastida. Parasitol Today 1999;15:372&#226;&#8364;&#8220;378. [PubMed: <br />                                               10461166] <br />                                           Coderre JA, Beverley SM, Schimke RT, Santi DV. Overproduction bifunctional thymidylate <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               synthetase-dihydrofolate reductase DNA amplification methotrexate-resistant Leishmania <br />                                               tropica. Proc Natl Acad Sci U S 1983;80:2132&#226;&#8364;&#8220;2136. [PubMed: 6572966] <br />                                           Cruz  Beverley SM. Gene replacement parasitic protozoa. Nature 1990;348:171&#226;&#8364;&#8220;173. [PubMed: <br />                                               2234081] <br />                                           Cruz  Coburn C, Beverley SM. Double targeted gene replacement creating null mutants. <br />                                               Proceedings National Academy Sciences 1991;88:7170&#226;&#8364;&#8220;7174. <br />                                           Cruz AK, Titus R, Beverley SM. Plasticity chromosome number testing essential genes                                               Leishmania targeting. Proc Natl Acad Sci U S 1993;90:1599&#226;&#8364;&#8220;1603. [PubMed: 8381972] <br />                                           Di Pietro E, Sirois J, Tremblay ML, MacKenzie  Mitochondrial NAD-dependent <br />                                               methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase essential                                               embryonic development. Mol Cell Biol 2002;22:4158&#226;&#8364;&#8220;4166. [PubMed: 12024029] <br />                                           Dumas C, Ouellette M, Tovar J, Cunningham ML, Fairlamb AH, Tamar S, Olivier M, Papadopoulou B. <br />                                               Disruption trypanothione reductase gene Leishmania decreases ability survive <br />                                               oxidative stress macrophages. EMBO J 1997;16:2590&#226;&#8364;&#8220;2598. [PubMed: 9184206] <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                  Page 16 <br />  <br />  <br />                                           El-Sayed NM, Myler PJ, Blandin G, Berriman M, Crabtree J, Aggarwal G, Caler E, Renauld H, Worthey <br />                                               EA, Hertz-Fowler C, Ghedin E, Peacock C, Bartholomeu DC, Haas BJ, Tran  Wortman JR, <br />                                               Alsmark UC, Angiuoli S, Anupama  Badger J, Bringaud F, Cadag E, Carlton JM, Cerqueira GC, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Creasy T, Delcher AL, Djikeng  Embley TM, Hauser C, Ivens AC, Kummerfeld SK, Pereira-Leal <br />                                               JB, Nilsson D, Peterson J, Salzberg SL, Shallom J, Silva JC, Sundaram J, Westenberger S, White O, <br />                                               Melville SE, Donelson JE, Andersson B, Stuart KD, Hall N. Comparative genomics                                               trypanosomatid parasitic protozoa. Science 2005;309:404&#226;&#8364;&#8220;409. [PubMed: 16020724] <br />                                           El Fadili  Kundig C, Ouellette M. Characterization folylpolyglutamate synthetase gene                                               polyglutamylation folates protozoan parasite Leishmania. Mol Biochem Parasitol <br />                                               2002;124:63&#226;&#8364;&#8220;71. [PubMed: 12387851] <br />                                           Fairlamb AH. Metabolic pathway analysis trypanosomes malaria parasites. Philos Trans R Soc <br />                                               Lond B Biol Sci 2002;357:101&#226;&#8364;&#8220;107. [PubMed: 11839187] <br />                                           Forsburg SL. art design genetic screens: yeast. Nat Rev Genet 2001;2:659&#226;&#8364;&#8220;668. [PubMed: <br />                                               11533715] <br />                                           Hanson AD, Gage DA, Shachar-Hill Y. Plant carbon metabolism engineering. Trends Plant <br />                                               Sci 2000;5:206&#226;&#8364;&#8220;213. [PubMed: 10785666] <br />                                           Hanson AD, Roje S. Carbon Metabolism Higher Plants. Annu Rev Plant Physiol Plant Mol Biol <br />                                               2001;52:119&#226;&#8364;&#8220;137. [PubMed: 11337394] <br />                                           Hardy LW, Matthews W, Nare B, Beverley SM. Biochemical genetic tests inhibitors                                               Leishmania pteridine pathways. Exp Parasitol 1997;87:157&#226;&#8364;&#8220;169. [PubMed: 9371081] <br />                                           Hatefi Y, Osborn MJ, Kay LD, Huennekens FM. Hydroxymethyl tetrahydrofolic dehydrogenase. J Biol <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Chem 1957;227:637&#226;&#8364;&#8220;647. [PubMed: 13462986] <br />                                           Ilgoutz SC, Mullin KA, Southwell BR, McConville MJ. Glycosylphosphatidylinositol biosynthetic <br />                                               enzymes localized stable tubular subcompartment endoplasmic reticulum                                               Leishmania mexicana. EMBO J 1999a;18:3643&#226;&#8364;&#8220;3654. [PubMed: 10393180] <br />                                           Ilgoutz SC, Zawadzki JL, Ralton JE, McConville MJ. Evidence free GPI glycolipids essential <br />                                               growth Leishmania mexicana. EMBO J 1999b;18:2746&#226;&#8364;&#8220;2755. [PubMed: 10329621] <br />                                           Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, Sisk E, Rajandream MA, <br />                                               Adlem E, Aert R, Anupama  Apostolou  Attipoe P, Bason N, Bauser C, Beck  Beverley SM, <br />                                               Bianchettin G, Borzym K, Bothe G, Bruschi CV, Collins M, Cadag E, Ciarloni L, Clayton C, Coulson <br />                                               RM, Cronin  Cruz AK, Davies RM, Gaudenzi J, Dobson  Duesterhoeft  Fazelina G, <br />                                               Fosker N, Frasch AC, Fraser  Fuchs M, Gabel C, Goble  Goffeau  Harris D, Hertz-Fowler C, <br />                                               Hilbert H, Horn D, Huang Y, Klages S, Knights  Kube M, Larke N, Litvin L, Lord  Louie T, <br />                                               Marra M, Masuy D, Matthews K, Michaeli S, Mottram JC, Muller-Auer S, Munden H, Nelson S, <br />                                               Norbertczak H, Oliver K, O&#226;&#8364;&#8482;Neil S, Pentony M, Pohl TM, Price C, Purnelle B, Quail MA, <br />                                               Rabbinowitsch E, Reinhardt R, Rieger M, Rinta J, Robben J, Robertson L, Ruiz JC, Rutter S, Saunders <br />                                               D, Schafer M, Schein J, Schwartz DC, Seeger K, Seyler  Sharp S, Shin H, Sivam D, Squares R, <br />                                               Squares S, Tosato V, Vogt C, Volckaert G, Wambutt R, Warren T, Wedler H, Woodward J, Zhou S, <br />                                               Zimmermann W, Smith DF, Blackwell JM, Stuart KD, Barrell B, et al. genome                                               kinetoplastid parasite, Leishmania major. Science 2005;309:436&#226;&#8364;&#8220;442. [PubMed: 16020728] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Kedzierski L, Zhu Y, Handman E. Leishmania vaccines: progress problems. Parasitology 2006;133 <br />                                               (Suppl):S87&#226;&#8364;&#8220;112. [PubMed: 17274851] <br />                                           Kozak M. Comparison initiation protein synthesis procaryotes, eucaryotes, organelles. <br />                                               Microbiol Rev 1983;47:1&#226;&#8364;&#8220;45. [PubMed: 6343825] <br />                                           Li Y, Holmes WB, Appling DR, RajBhandary UL. Initiation protein synthesis Saccharomyces <br />                                               cerevisiae mitochondria formylation initiator tRNA. J Bacteriol 2000;182:2886&#226;&#8364;&#8220;2892. <br />                                               [PubMed: 10781559] <br />                                           McConville MJ, Souza D, Saunders E, Likic VA, Naderer T. Living phagolysosome; metabolism <br />                                               Leishmania amastigotes. Trends Parasitol 2007;23:368&#226;&#8364;&#8220;375. [PubMed: 17606406] <br />                                           Medina-Acosta E, Cross GA. Rapid isolation DNA trypanosomatid protozoa using simple <br />                                               &#226;&#8364;&#732;mini-prep&#226;&#8364;&#8482; procedure. Mol Biochem Parasitol 1993;59:327&#226;&#8364;&#8220;329. [PubMed: 8341329] <br />                                           Mejia NR, MacKenzie  NAD-dependent methylenetetrahydrofolate dehydrogenase- <br />                                               methenyltetrahydrofolate cyclohydrolase transformed cells mitochondrial enzyme. Biochem <br />                                               Biophys Res Commun 1988;155:1&#226;&#8364;&#8220;6. [PubMed: 3261979] <br />  <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                   Page 17 <br />  <br />  <br />                                           Mishra J, Saxena  Singh S. Chemotherapy leishmaniasis: past, present future. Curr Med Chem <br />                                               2007;14:1153&#226;&#8364;&#8220;1169. [PubMed: 17456028] <br />                                           Moore MR, O&#226;&#8364;&#8482;Brien  Ljungdahl LG. Purification characterization <span id='am-70' about='obo:IMR_0200025' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-71' property="oboInOwl:hasDbXref" content="KEGG:C00153" datatype="xsd:string"></span><span id='am-72' property="rdfs:label" content="Nicotinamide" datatype="xsd:string"></span><span id='am-73' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-74' property="oboInOwl:id" content="IMR:0200025" datatype="xsd:string"></span>nicotinamide</span> <span id='am-12' about='obo:IMR_0200350' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-13' property="oboInOwl:hasDbXref" content="KEGG:C00147" datatype="xsd:string"></span><span id='am-14' property="rdfs:label" content="Adenine" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:id" content="IMR:0200350" datatype="xsd:string"></span>adenine</span> <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               dinucleotide-dependent methylenetetrahydrofolate dehydrogenase Clostridium <br />                                               formicoaceticum. J Biol Chem 1974;249:5250&#226;&#8364;&#8220;5253. [PubMed: 4153026] <br />                                           Nare B, Luba J, Hardy LW, Beverley S. New approaches Leishmania chemotherapy: pteridine <br />                                               reductase 1 (PTR1) target modulator antifolate sensitivity. Parasitology 1997;114:S101&#226;&#8364;&#8220; <br />                                               110. [PubMed: 9309772] <br />                                           Newton DT, Creuzenet C, Mangroo D. Formylation essential initiation protein synthesis                                               eubacteria. J Biol Chem 1999;274:22143&#226;&#8364;&#8220;22146. [PubMed: 10428776] <br />                                           Nour JM, Rabinowitz JC. Isolation, characterization, structural organization 10- <br />                                               formyltetrahydrofolate synthetase spinach leaves. J Biol Chem 1991;266:18363&#226;&#8364;&#8220;18369. <br />                                               [PubMed: 1917961] <br />                                           Nzila  Ward SA, Marsh K, Sims PF, Hyde JE. Comparative folate metabolism humans malaria <br />                                               parasites  : pointers malaria treatment cancer chemotherapy. Trends Parasitol <br />                                               2005;21:292&#226;&#8364;&#8220;298. [PubMed: 15922251] <br />                                           Opperdoes FR, Coombs GH. Metabolism Leishmania: proven predicted. Trends Parasitol <br />                                               2007;23:149&#226;&#8364;&#8220;158. [PubMed: 17320480] <br />                                           Ouellette M, Drummelsmith J, El-Fadili  Kundig C, Richard D, Roy G. Pterin transport metabolism <br />                                               Leishmania related trypanosomatid parasites. Int J Parasitol 2002;32:385&#226;&#8364;&#8220;398. [PubMed: <br />                                               11849635] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Papadopoulou B, Dumas C. Parameters controlling rate gene targeting frequency protozoan <br />                                               parasite Leishmania. Nucleic Acids Res 1997;25:4278&#226;&#8364;&#8220;4286. [PubMed: 9336458] <br />                                           Parle-McDermott  Pangilinan F, Mills JL, Signore CC, Molloy  Cotter  Conley M, Cox C, Kirke <br />                                               PN, Scott JM, Brody LC. polymorphism MTHFD1 gene increases mother&#226;&#8364;&#8482;s risk having <br />                                               unexplained second trimester pregnancy loss. Mol Hum Reprod 2005;11:477&#226;&#8364;&#8220;480. [PubMed: <br />                                               16123074] <br />                                           Patel H, Pietro ED, MacKenzie  Mammalian fibroblasts lacking mitochondrial NAD+-dependent <br />                                               methylenetetrahydrofolate dehydrogenase-cyclohydrolase glycine auxotrophs. J Biol Chem <br />                                               2003;278:19436&#226;&#8364;&#8220;19441. [PubMed: 12646567] <br />                                           Pawelek PD, MacKenzie  Methenyltetrahydrofolate cyclohydrolase rate limiting enzymatic <br />                                               conversion 10-formyltetrahydrofolate 5,10-methylenetetrahydrofolate bifunctional <br />                                               dehydrogenase-cyclohydrolase enzymes. Biochemistry 1998;37:1109&#226;&#8364;&#8220;1115. [PubMed: 9454603] <br />                                           Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC, Quail MA, Peters N, Adlem E, Tivey  Aslett M, <br />                                               Kerhornou  Ivens  Fraser  Rajandream MA, Carver T, Norbertczak H, Chillingworth T, Hance <br />                                                Jagels K, Moule S, Ormond D, Rutter S, Squares R, Whitehead S, Rabbinowitsch E, Arrowsmith <br />                                               C, White B, Thurston S, Bringaud F, Baldauf SL, Faulconbridge  Jeffares D, Depledge DP, Oyola <br />                                                Hilley JD, Brito LO, Tosi LR, Barrell B, Cruz AK, Mottram JC, Smith DF, Berriman M. <br />                                               Comparative genomic analysis Leishmania species cause diverse human disease. Nat <br />                                               Genet 2007;39:839&#226;&#8364;&#8220;847. [PubMed: 17572675] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Prabhu V, Chatson KB, Lui H, Abrams GD, King J. Effects sulfanilamide methotrexate 13C <br />                                               fluxes glycine decarboxylase/serine hydroxymethyltransferase enzyme                                               arabidopsis. Plant Physiol 1998;116:137&#226;&#8364;&#8220;144. [PubMed: 9449840] <br />                                           Rabinowitz JC. Preparation properties 5,10-methenyltetrahydrofolic acid 10- <br />                                               Formyltetrahydrofolic acid. Methods Enzymology 1963;6:814&#226;&#8364;&#8220;815. <br />                                           Rabinowitz JC, Pricer Jr. Formyltetrahydrofolate synthetase.  Isolation crystallization                                               enzyme. J Biol Chem 1962;237:2898&#226;&#8364;&#8220;2902. [PubMed: 14489619] <br />                                           RajBhandary UL. Initiator transfer RNAs. J Bacteriol 1994;176:547&#226;&#8364;&#8220;552. [PubMed: 7507918] <br />                                           RajBhandary UL. surprises translation: initiation initiator tRNA. Proc Natl Acad Sci <br />                                               U S 2000;97:1325&#226;&#8364;&#8220;1327. [PubMed: 10677458] <br />                                           Robinson KA, Beverley SM. Improvements transfection efficiency tests RNA interference <br />                                               (RNAi) approaches protozoan parasite Leishmania. Mol Biochem Parasitol 2003;128:217&#226;&#8364;&#8220; <br />                                               228. [PubMed: 12742588] <br />  <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                     Page 18 <br />  <br />  <br />                                           Schmidt  Wu H, MacKenzie  Chen VJ, Bewly JR, Ray JE, Toth JE, Cygler M. Structures                                               inhibitor complexes provide insight reaction mechanism human <br />                                               methylenetetrahydrofolate dehydrogenase/cyclohydrolase. Biochemistry 2000;39:6325&#226;&#8364;&#8220;6335. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               [PubMed: 10828945] <br />                                           Schweitzer BI, Dicker AP, Bertino JR. Dihydrofolate reductase therapeutic target. FASEB J <br />                                               1990;4:2441&#226;&#8364;&#8220;2452. [PubMed: 2185970] <br />                                           Scott DA, Coombs GH, Sanderson  Folate utilization Leishmania species identification <br />                                               intracellular derivatives folate-metabolizing enzymes. Mol Biochem Parasitol 1987;23:139&#226;&#8364;&#8220; <br />                                               149. [PubMed: 3574356] <br />                                           Scott DA, Hickerson SM, Vickers TJ, Beverley SM. role mitochondrial glycine cleavage <br />                                               complex metabolism virulence protozoan parasite Leishmania major. J Biol Chem <br />                                               2008;283:155&#226;&#8364;&#8220;165. [PubMed: 17981801] <br />                                           Sen N, Banerjee B, Gupta SS, Das BB, Ganguly  Majumder HK. Leishmania donovani: <br />                                               dyskinetoplastid cells survive proliferate presence pyruvate uridine                                               undergo apoptosis treatment camptothecin. Exp Parasitol 2007;115:215&#226;&#8364;&#8220;219. [PubMed: <br />                                               17027973] <br />                                           Spencer AC, Spremulli LL. Interaction mitochondrial initiation factor 2 mitochondrial fMet- <br />                                               tRNA. Nucleic Acids Res 2004;32:5464&#226;&#8364;&#8220;5470. [PubMed: 15477394] <br />                                           Stanger O. Physiology <span id='am-28' about='obo:IMR_0200356' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-29' property="oboInOwl:id" content="IMR:0200356" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasDbXref" content="KEGG:C00504" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="Folic acid" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>folic acid</span> health disease. Curr Drug Metab 2002;3:211&#226;&#8364;&#8220;223. [PubMed: <br />                                               12003352] <br />                                           Szewczyk E, Nayak T, Oakley CE, Edgerton H, Xiong Y, Taheri-Talesh N, Osmani SA, Oakley BR. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Fusion PCR gene targeting Aspergillus nidulans. Nat Protoc 2006;1:3111&#226;&#8364;&#8220;3120. [PubMed: <br />                                               17406574] <br />                                           Tan LU, Drury EJ, MacKenzie  Methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate <br />                                               cyclohydrolase-formyltetrahydrofolate synthetase. multifunctional protein porcine liver. J <br />                                               Biol Chem 1977;252:1117&#226;&#8364;&#8220;1122. [PubMed: 838698] <br />                                           Tan TH, Bochud-Allemann N, Horn EK, Schneider  Eukaryotic-type elongator tRNAMet                                               Trypanosoma brucei formylated import mitochondria. Proc Natl Acad Sci U S                                               2002;99:1152&#226;&#8364;&#8220;1157. [PubMed: 11792845] <br />                                           Temple C Jr, Bennett LL Jr, Rose JD, Elliott RD, Montgomery JA, Mangum JH. Synthesis pseudo <br />                                               cofactor analogues potential inhibitors folate enzymes. J Med Chem 1982;25:161&#226;&#8364;&#8220;166. <br />                                               [PubMed: 7057422] <br />                                           RL. Antimicrobial dihydrofolate reductase inhibitors--achievements future options: review. J <br />                                               Chemother 2004;16:3&#226;&#8364;&#8220;12. [PubMed: 15077993] <br />                                           Tonkinson JL, Habeck LL, Toth JE, Mendelsohn LG, Bewley J, Shackelford KA, Gates SB, Ray J, Chen <br />                                               VJ. antiproliferative cell cycle effects 5,6,7, 8-tetrahydro-N5, N10-carbonylfolic acid,                                               inhibitor methylenetetrahydrofolate dehydrogenase, potentiated <span id='am-99' about='obo:IMR_0200173' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-100' property="rdfs:label" content="Hypoxanthine" datatype="xsd:string"></span><span id='am-101' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-102' property="oboInOwl:id" content="IMR:0200173" datatype="xsd:string"></span><span id='am-103' property="oboInOwl:hasDbXref" content="KEGG:C00262" datatype="xsd:string"></span>hypoxanthine</span>. J Pharmacol <br />                                               Exp Ther 1998;287:315&#226;&#8364;&#8220;321. [PubMed: 9765352] <br />                                           Varshney U, Lee CP, RajBhandary UL. elongator tRNA initiator tRNA. Proc Natl Acad Sci U <br />                                               S 1993;90:2305&#226;&#8364;&#8220;2309. [PubMed: 8460138] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Vergnes B, Sereno D, Tavares J, Cordeiro-da-Silva  Vanhille L, Madjidian-Sereno N, Depoix D, <br />                                               Monte-Alegre  Ouaissi  Targeted disruption cytosolic SIR2 deacetylase discloses essential <br />                                               role Leishmania survival proliferation. Gene 2005;363:85&#226;&#8364;&#8220;96. [PubMed: 16236469] <br />                                           Vial L, Gomez P, Panvert M, Schmitt E, Blanquet S, Mechulam Y. Mitochondrial methionyl-tRNAfMet <br />                                               formyltransferase Saccharomyces cerevisiae: gene disruption tRNA substrate specificity. <br />                                               Biochemistry 2003;42:932&#226;&#8364;&#8220;939. [PubMed: 12549912] <br />                                           Vickers TJ, Murta SMF, Mandell MA, Beverley SM. 10-formyl-tetrahydrofolate synthesis exclusively <br />                                               cytosolic trypanosomatid parasite. Leishmania major. 2008(submitted) <br />                                           Vickers TJ, Orsomando G, la Garza RD, Scott DA, Kang  Hanson AD, Beverley SM. Biochemical <br />                                               genetic analysis methylenetetrahydrofolate reductase Leishmania metabolism                                               virulence. J Biol Chem 2006;281:38150&#226;&#8364;&#8220;38158. [PubMed: 17032644] <br />                                           Weber S. Light-driven enzymatic catalysis DNA repair: review recent biophysical studies                                               photolyase. Biochim Biophys Acta 2005;1707:1&#226;&#8364;&#8220;23. [PubMed: 15721603] <br />  <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                                 Page 19 <br />  <br />  <br />                                           West MG, Horne DW, Appling DR. Metabolic role cytoplasmic isozymes 5,10- <br />                                              methylenetetrahydrofolate dehydrogenase Saccharomyces cerevisiae. Biochemistry <br />                                              1996;35:3122&#226;&#8364;&#8220;3132. [PubMed: 8608153] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Zhang Y, Desharnais J, Marsilje TH, Li C, Hedrick MP, Gooljarsingh LT, Tavassoli  Benkovic SJ, <br />                                              Olson AJ, Boger DL, Wilson IA. Rational design, synthesis, evaluation, crystal structure                                              potent inhibitor human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8- <br />                                              tetrahydrofolic acid. Biochemistry 2003;42:6043&#226;&#8364;&#8220;6056. [PubMed: 12755606] <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                          Page 20 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           FIG. 1. 10-formyl-THF metabolism Leishmania <br />                                           Following synthesis activity dihydrofolate reductase (DHFR, encoded                                           bifunctional DHFR-TS) pteridine reductase 1 (PTR1), tetrahydrofolate (THF) enter C1 <br />                                           metabolic pathways direct formylation ATP-dependent reaction formate- <br />                                           tetrahydrofolate ligase (FTL, LmjF30.2600). Alternatively, THF converted 5,10- <br />                                           methylene-tetrahydrofolate (5,10-CH2-THF) activity serine <br />                                           hydroxymethyltransferase (SHMT). 10-CHO-THF generated steps 5,10- <br />                                           methylene-tetrahydrofolate (5,10-CH2-THF), oxidation 5,10-methenyl- <br />                                           tetrahydrofolate (5,10-CH=THF) NADP+-dependent methylenetetrahydrofolate <br />                                           dehydrogenase (DH, LmjF26.0320), hydrolysis 10-CHO-THF                                           methenyltetrahydrofolate cyclohydrolase (CH, LmjF26.0320). L. major DH CH <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           activities contained single bifunctional protein DHCH1, like FTL localized <br />                                           exclusively cytosol (Vickers et al., 2008). 10-CHO-THF used novo <br />                                           purine synthetic pathway organisms, pathway absent Leishmania                                           parasitic protozoans (Carter et al., 2008). Current data suggest 10-CHO-THF utilized <br />                                           mitochondrion methionyl-tRNA formylation, unique function far <br />                                           uncovered genomic metabolic studies Leishmania. <br />  <br />  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                         Page 21 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           FIG. 2. Attempts generate dhch1&#226;&#710;&#8217; null mutants &#226;&#8364;&#732;classic&#226;&#8364;&#8482; double replacements <br />                                            Planned deletion DHCH1 ORF homologous gene replacement using targeting <br />                                           fragments PAC HYG resistance markers. round, parasites transfected <br />                                           construct separately; diagram round starting PAC shown. <br />                                           Heterozygous replacement lines obtained high efficiency. second round,                                           +/PAC heterozygote (formally, &#206;&#8221;dhch1::PAC/DHCH) transfected HYG targeting <br />                                           fragment, expectation yielding homozogous dhch1&#226;&#710;&#8217; null mutants. Instead,                                           aneuploid parasites showing planned replacements retaining WT DHCH1 <br />                                           recovered (formally, &#206;&#8221;dhch1::PAC/DHCH/&#206;&#8221;dhch1::SAT/&#206;&#8221;dhch1::PAC/DHCH1). B. <br />                                           PCR tests planned PAC replacements DHCH1. Homologous replacement visualized <br />                                           PCR amplification using primer directed sequences located PAC ORF, <br />                                           primer located DHCH1 chromosome outside targeting fragment (indicated                                           heavy line) 5&#226;&#8364;&#178; (white arrows) 3&#226;&#8364;&#178; (black arrow) (SMB2731/2558                                           SMB2771/2557, Table S1). sizes predicted PCR products shown. WT, wild- <br />                                           type DNA; NC, negative control  DNA template), #1&#226;&#8364;&#8220;8, independent lines                                           PAC replacements DHCH1. C, PCR tests planned HYG replacements DHCH1. NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           experiment similar described panel B, primers directed                                           sequences located HYG targeting fragment (SMB2731/2562 SMB2771/2561, Table <br />                                           S1). #1&#226;&#8364;&#8220;6, independent lines HYG replacements DHCH1. D. PCR tests showing <br />                                           retention DHCH1 second round transfectants. Amplifications performed using <br />                                           primers directed sequences L. major DHCH1 ORF (SMB3125/3126, Table <br />                                           S1). Lines # 1 &#226;&#8364;&#8220; 4 represent double replacement PAC/HYG lines # 5 &#226;&#8364;&#8220; 8 HYG/ <br />                                           PAC. <br />  <br />  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                       Page 22 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           FIG. 3. Deletion chromosomal DHCH1 presence ectopic DHCH1 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Scheme deletion chromosomal DHCH1 presence ectopically expressed <br />                                           DHCH1.  pXNG4-DHCH1 episomal expression construct transfected                                           DHCH1/&#206;&#8221;dhch1::PAC heterozygote described Fig. 2A; 10/10 transfectants analyzed                                           confirmed predicted genotype depicted. DHCH1/&#206;&#8221;dhch1::PAC [pXNG4- <br />                                           DHCH1] lines transfected HYG DHCH targeting fragment selected                                           resistance antibiotics; 12 clonal lines tested, showed planned <br />                                           replacement chromosomal DHCH1 locus (formally, &#206;&#8221;dhch1::HYG DHCH1/ <br />                                           &#206;&#8221;dhch1::PAC [pXNG4-DHCH1]). <br />                                           B &#226;&#8364;&#8220; PCR tests showing loss chromosomal DHCH1. distinguish ectopic DHCH1 <br />                                           chromosomal locus, DNA candidate lines subjected PCR tests using                                           using primer directed sequences located DHCH1 ORFt, primer located <br />                                           DHCH1 chromosome outside targeting fragment 5&#226;&#8364;&#178; (SMB2731/3126,, <br />                                           Table S1). WT, wild-type DNA control; NC, negative control lacking DNA template.  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                      Page 23 <br />  <br />  <br />                                           arrow marks size predicted fragment WT DNA, absent                                           chromosomal dhch1&#226;&#710;&#8217; knockouts. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                Mol Microbiol. Author manuscript; available PMC 2009 June 8. <br />                             Murta et al.                                                                                          Page 24 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           FIG. 4. Deletion chromosomal DHCH1 presence ectopic FTL overexpression <br />                                            Scheme deletion chromosomal DHCH1 presence ectopically expressed <br />                                           FTL. pXNG4-FTLepisomal expression construct transfected DHCH1/PAC <br />                                           (DHCH1/&#206;&#8221;dhch1::PAC) heterozygote described Fig. 2A; 10/10 transfectants analyzed                                           predicted genotype depicted. DHCH1/PAC/+FTL lines (DHCH1/&#206;&#8221;dhch1::PAC <br />                                           [pXNG4-FTL]) transfected HYG DHCH1 targeting fragment described <br />                                           legend Fig. 3A; 12 clonal lines tested, showed planned replacement                                           chromosomal DHCH1 locus dhch1&#226;&#710;&#8217;/+FTL (&#206;&#8221;dhch1::HYG DHCH1/ <br />                                           &#206;&#8221;dhch1::PAC [pXNG4-FTL]). <br />                                           B &#226;&#8364;&#8220; PCR tests showing loss chromosomal DHCH1. performed described                                           legend Fig. 3B. NC, negative control lacking DNA; WT, WT DNA; pXNG-DHCH1, <br />                                           WT transfected pXNG-DHCH1. Pac4, Pac5, Hyg7 different lines showing <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           absence predicted chromosomal DHCH1 PCR product (shown arrow). C. Western <br />                                           blot showing loss DHCH1 expression dhch1&#226;&#710;&#8217;/+FTL transfectants. lines          <br /> </body></html>